Shots:

• Alcon acquires PowerVision- in all stock transaction paying $285M to PowerVision with additional payment based on regulatory & commercial milestones expected to initiate in 2023
• The focus of the acquisition is to expand Alcon’s ophthalmic portfolio by using PowerVision’sadvanced technology intraocular lenses (AT-IOLS) to deliver therapies cataract surgery patients desiring spectacle independence
• PowerVision’s AT-IOLS is used to develop fluid-based accommodating intraocular lenses that utilize eye's natural accommodating response in presbyopia providing near & intermediate vision

Ref: Alcon | Image: Cnbc